The Urethane Blog

Everchem Updates

VOLUME XXI

September 14, 2023

Everchem’s Closers Only Club

Everchem’s exclusive Closers Only Club is reserved for only the highest caliber brass-baller salesmen in the chemical industry. Watch the hype video and be introduced to the top of the league: read more

UPS and CVS deliver prescription medicine via drone to US residential customers for the first time

_mobile0c9a66_assets_img_media_UPS_CVS_Drone_5

UPS is rolling along with its drone delivery program, working with partner CVS Pharmacy to deliver prescription drugs to customer doorsteps via its newly deployed commercial drones. UPS delivered medications to two paying customers on November 1 using the Matternet M2 drone system that the logistics company is using in partnership with Matternet ..

UPS received approval last month from the FAA to fly its fleet of commercial drones in service of customers, and now it plans to iterate its drone delivery program “in the coming months,” with the aim of ensuring that it can deploy UAVs in a commercial capacity at increasing scale. It also launched “UPS Flight Forward,” a dedicated division focused on autonomous drone delivery.

For these early deliveries, drones were loaded with prescriptions filled by pharmacists at a CVS location in Cary, NC. Once a UPS employee loaded the cargo onto the drones, they flew autonomously from the store location to nearby customer homes, dropping off the packages from a hover height of around 20 feet above these locations. One of the customers has mobility challenges that would make travel to a CVS store for prescription pickup difficult, UPS points out.

This isn’t the first time UPS has deployed drones in a healthcare industry setting: The company has been working with Mattternet and WakeMed Hospital in Raleigh, doing commercial deliveries of medical samples in a B2B setting.

UPS and CVS deliver prescription medicine via drone to US residential customers for the first time

November 15, 2019

Health Care Transparency

In Shock To $3.5 Trillion Healthcare Industry, Admin Will Force Hospitals To Disclose “Secret” Insurance Rates

In a move that will send shockwaves across the $3.5 trillion US healthcare industry, on Friday the Trump administration unveiled a plan that would – for the first time – force hospitals and insurers to disclose their secret negotiated rates, the WSJ reported.

In hopes of bringing some transparency and openness to a pathologically opaque industry, one which many have blamed for being behind the explosion in US underfunded liabilities to more than $100 trillion, administration officials said the final rule will compel hospitals in 2021 to publicize the rates they negotiate with individual insurers for all services, including drugs, supplies, facility fees and care by doctors who work for the facility. The White House would also propose extending the disclosure requirement to the $670 billion health-insurance industry. Insurance companies and group health plans that cover employees would have to disclose negotiated rates, as well as previously paid rates for out-of-network treatment, in computer-searchable file formats.

As the WSJ notes, the proposal covering insurers is the newest part of the price-disclosure initiative, and would include the private-employer market, where about 158 million people get their health insurance. Insurers and group health plans would have to put the negotiated rates into a file that third-party developers could incorporate into shopping tools. As with hospitals, insurers will have to create a web-based tool for beneficiaries that discloses the list price, the negotiated rate, cost sharing, and the amount left on a plan deductible, as well as allowable out-of-network rates.

The requirements, which are more far-reaching than industry leaders had expected, could upend commercial health-care markets, which are rife with purposefully complex systems of hidden charges and secret discounts which enable the fleecing of either end users or chronically  underfunded government healthcare programs. The price-disclosure initiative has become a cornerstone of the president’s 2020 re-election health strategy, despite threats of legal action from industry.

“Right now there is too much arbitrage in the system,” a senior administration official said in an interview Thursday with The Wall Street Journal. “There are a ton of vested interests who will oppose this. We expect to get sued. We’re really goring people’s oxes.”

Hospitals and insurers typically treat specific prices for medical services as closely held secrets, with contracts between the insurers and hospital systems generally bound by confidentiality agreements. Policy makers, employers and patients are often unable to see clearly which hospital systems and doctor practices are driving high costs.

Ironically just a few days ago we showed why “US Healthcare Costs Are Exploding“, and the primary culprit was soaring insurance and medical care service fees. If there is one thing that could potentially put a dent in this exponential surge, it is the elimination of all the various secret price deals and arrangements.

Why is transaprency good? Because as studies have shown, consumers are often required to pay more out of pocket when they don’t have the price information they need to comparison shop. Employer health-plan deductibles are outpacing wage growth and have risen to an average $1,655 for a single plan, according to a September survey by the Kaiser Family Foundation. Workers on average pay $6,015 toward the cost of their coverage.

Taken together, the WSJ notes, “the price-disclosure initiatives could reshape the $3.5 trillion health-care industry.”

The good news: the much needed transparency finally may bring some – literal – price discovery to what has traditionally been the most opaque, and lucrative, sector for the aging and chronically obese US population.

Meanwhile, as Americans lament soaring prices of, well, everything, after shelter and rent costs, the second biggest drain of US household income and savings is insurance premiums.

https://www.zerohedge.com/health/shock-35-trillion-healthcare-industry-trump-admin-will-force-hospitals-disclose-secret

November 15, 2019

Health Care Transparency

In Shock To $3.5 Trillion Healthcare Industry, Admin Will Force Hospitals To Disclose “Secret” Insurance Rates

In a move that will send shockwaves across the $3.5 trillion US healthcare industry, on Friday the Trump administration unveiled a plan that would – for the first time – force hospitals and insurers to disclose their secret negotiated rates, the WSJ reported.

In hopes of bringing some transparency and openness to a pathologically opaque industry, one which many have blamed for being behind the explosion in US underfunded liabilities to more than $100 trillion, administration officials said the final rule will compel hospitals in 2021 to publicize the rates they negotiate with individual insurers for all services, including drugs, supplies, facility fees and care by doctors who work for the facility. The White House would also propose extending the disclosure requirement to the $670 billion health-insurance industry. Insurance companies and group health plans that cover employees would have to disclose negotiated rates, as well as previously paid rates for out-of-network treatment, in computer-searchable file formats.

As the WSJ notes, the proposal covering insurers is the newest part of the price-disclosure initiative, and would include the private-employer market, where about 158 million people get their health insurance. Insurers and group health plans would have to put the negotiated rates into a file that third-party developers could incorporate into shopping tools. As with hospitals, insurers will have to create a web-based tool for beneficiaries that discloses the list price, the negotiated rate, cost sharing, and the amount left on a plan deductible, as well as allowable out-of-network rates.

The requirements, which are more far-reaching than industry leaders had expected, could upend commercial health-care markets, which are rife with purposefully complex systems of hidden charges and secret discounts which enable the fleecing of either end users or chronically  underfunded government healthcare programs. The price-disclosure initiative has become a cornerstone of the president’s 2020 re-election health strategy, despite threats of legal action from industry.

“Right now there is too much arbitrage in the system,” a senior administration official said in an interview Thursday with The Wall Street Journal. “There are a ton of vested interests who will oppose this. We expect to get sued. We’re really goring people’s oxes.”

Hospitals and insurers typically treat specific prices for medical services as closely held secrets, with contracts between the insurers and hospital systems generally bound by confidentiality agreements. Policy makers, employers and patients are often unable to see clearly which hospital systems and doctor practices are driving high costs.

Ironically just a few days ago we showed why “US Healthcare Costs Are Exploding“, and the primary culprit was soaring insurance and medical care service fees. If there is one thing that could potentially put a dent in this exponential surge, it is the elimination of all the various secret price deals and arrangements.

Why is transaprency good? Because as studies have shown, consumers are often required to pay more out of pocket when they don’t have the price information they need to comparison shop. Employer health-plan deductibles are outpacing wage growth and have risen to an average $1,655 for a single plan, according to a September survey by the Kaiser Family Foundation. Workers on average pay $6,015 toward the cost of their coverage.

Taken together, the WSJ notes, “the price-disclosure initiatives could reshape the $3.5 trillion health-care industry.”

The good news: the much needed transparency finally may bring some – literal – price discovery to what has traditionally been the most opaque, and lucrative, sector for the aging and chronically obese US population.

Meanwhile, as Americans lament soaring prices of, well, everything, after shelter and rent costs, the second biggest drain of US household income and savings is insurance premiums.

https://www.zerohedge.com/health/shock-35-trillion-healthcare-industry-trump-admin-will-force-hospitals-disclose-secret

November 13, 2019

Edge-Sweets History

Edge-Sweets was nice enough to give out an old book: A Glossary of Urethane Industry Terms at the recent PFA meeting (www.PFA.org) in Louisville, KY.

Here’s the history of the company:

Company History Timeline


1883
Frank Edge

ESCO [Edge-Sweets Company] got its start in 1883 when Frank Edge fabricated his first jigsaw blades.

1887
Frank Edge Company Formed

Building on this concept, Frank formed The Frank Edge Company in 1887 to produce saw blades for the booming furniture industry in Grand Rapids, Michigan.

1887-1953
The First 70 Years

The first 70 years of the company were spent supplying blades and equipment to the bustling furniture manufacturers.

1953
Edge Saw Formed

In 1953, Edge Saw was formed to manufacture the first saw for cutting flexible “foam rubber.”

1957
Growth

By 1957, the manufacture of foam cutting equipment was the main activity for Edge Saw and growth of the company kept pace with the fast growth of foam production in the U.S.

1971
Edge Conveyor

In 1971, Edge Conveyor was formed to supply specialized conveyors essential to economical foam production. With the advent of Edge Conveyor, the company expanded its production facilities and its engineering capabilities and offered the foam industry high volume production cutting lines to supplement foam fabrication on individual units.

1973
Purchase North American Urethanes [NAU]

In 1973, Edge purchased North American Urethanes (NAU), a company with several years experience in the engineering and manufacture of urethane metering and dispensing equipment. With the acquisition of NAU, Edge Industries became the only machinery company in the industry capable of supplying equipment for the production, processing, and cutting of soft or rigid foam. The acquisition of NAU’s Machinery Division added foam and elastomer dispensers to the product line and gave Edge the ability to provide “wet end” systems for flexible and rigid foam.

1985
Edge-Sweets Company Formed

In 1985, Edge-Sweets Company was formed as Edge merged with Martin Sweets Company of Louisville, Kentucky, a company who similarly specialized in the manufacture of machinery and equipment for processing and cutting of polyurethane foam products and other cellular and noncellular plastics.

2019
Today

Edge-Sweets Company, today referred to as ESCO, resides in a 70,000+ square foot facility in Grand Rapids, Michigan and offers the combined products and knowledge of both cutting and dispensing equipment, along with a unique ability to custom engineer systems.

https://www.edge-sweets.com/history.aspx

November 13, 2019

Edge-Sweets History

Edge-Sweets was nice enough to give out an old book: A Glossary of Urethane Industry Terms at the recent PFA meeting (www.PFA.org) in Louisville, KY.

Here’s the history of the company:

Company History Timeline


1883
Frank Edge

ESCO [Edge-Sweets Company] got its start in 1883 when Frank Edge fabricated his first jigsaw blades.

1887
Frank Edge Company Formed

Building on this concept, Frank formed The Frank Edge Company in 1887 to produce saw blades for the booming furniture industry in Grand Rapids, Michigan.

1887-1953
The First 70 Years

The first 70 years of the company were spent supplying blades and equipment to the bustling furniture manufacturers.

1953
Edge Saw Formed

In 1953, Edge Saw was formed to manufacture the first saw for cutting flexible “foam rubber.”

1957
Growth

By 1957, the manufacture of foam cutting equipment was the main activity for Edge Saw and growth of the company kept pace with the fast growth of foam production in the U.S.

1971
Edge Conveyor

In 1971, Edge Conveyor was formed to supply specialized conveyors essential to economical foam production. With the advent of Edge Conveyor, the company expanded its production facilities and its engineering capabilities and offered the foam industry high volume production cutting lines to supplement foam fabrication on individual units.

1973
Purchase North American Urethanes [NAU]

In 1973, Edge purchased North American Urethanes (NAU), a company with several years experience in the engineering and manufacture of urethane metering and dispensing equipment. With the acquisition of NAU, Edge Industries became the only machinery company in the industry capable of supplying equipment for the production, processing, and cutting of soft or rigid foam. The acquisition of NAU’s Machinery Division added foam and elastomer dispensers to the product line and gave Edge the ability to provide “wet end” systems for flexible and rigid foam.

1985
Edge-Sweets Company Formed

In 1985, Edge-Sweets Company was formed as Edge merged with Martin Sweets Company of Louisville, Kentucky, a company who similarly specialized in the manufacture of machinery and equipment for processing and cutting of polyurethane foam products and other cellular and noncellular plastics.

2019
Today

Edge-Sweets Company, today referred to as ESCO, resides in a 70,000+ square foot facility in Grand Rapids, Michigan and offers the combined products and knowledge of both cutting and dispensing equipment, along with a unique ability to custom engineer systems.

https://www.edge-sweets.com/history.aspx